Annals of Nuclear Medicine

Springer Nature

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Annals of Nuclear Medicine is a journal published by Springer Nature in Japan. It is listed in MEDLINE according to the sources read. Declared publication charge: 3,990 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Nature
ISSN
0914-7187 · 1864-6433
Country
Japan
Access
Not open access / not declared
Declared publication charge
3,990 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1987-01-01
Indexing
MEDLINE
APC
3,990 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
82 days received→accepted — computed from PubMed (n=99)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

3653

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

78

i10-index

1690

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
97%
ORCID iDs in current deposits
87%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
Annals of nuclear medicine (Print
Source type
journal
NLM unique ID (PubMed)
8913398
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Medical Imaging Techniques and Applications
  • Medical Imaging Techniques and Applications
  • Radiopharmaceutical Chemistry and Applications
  • Radiopharmaceutical Chemistry and Applications
  • Cardiac Imaging and Diagnostics
  • Cardiac Imaging and Diagnostics
  • Medical Imaging and Pathology Studies
  • Medical Imaging and Pathology Studies
Show all subjects (50)
  • Radiomics and Machine Learning in Medical Imaging
  • Radiomics and Machine Learning in Medical Imaging
  • Advanced MRI Techniques and Applications
  • Advanced MRI Techniques and Applications
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Thyroid Cancer Diagnosis and Treatment
  • Thyroid Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Treatment and Research
  • Cardiovascular Function and Risk Factors
  • Cardiovascular Function and Risk Factors
  • Advanced X-ray and CT Imaging
  • Advanced X-ray and CT Imaging
  • Glioma Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Neuroendocrine Tumor Research Advances
  • Neuroendocrine Tumor Research Advances
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • MRI in cancer diagnosis
  • MRI in cancer diagnosis
  • Dementia and Cognitive Impairment Research
  • Cerebrovascular and Carotid Artery Diseases
  • Dementia and Cognitive Impairment Research
  • Cerebrovascular and Carotid Artery Diseases
  • Radiation Dose and Imaging
  • Radiation Dose and Imaging
  • Esophageal Cancer Research and Treatment
  • Head and Neck Cancer Studies
  • Esophageal Cancer Research and Treatment
  • Head and Neck Cancer Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Bone health and treatments
  • Peptidase Inhibition and Analysis
  • Bone health and treatments
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Peptidase Inhibition and Analysis
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Diagnosis and Treatment

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: